{"product_id":"b2m-antibody-sc-f0921","title":"β2-microglobulin Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eβ2-microglobulin (B2M) is a serum protein with a molecular weight of 12 kDa, composed of 119 amino acids, and located on chromosome 15. It is a key component of the Major Histocompatibility Complex (MHC) class I molecule and has significant roles in cancer development and immune regulation. Depending on the literature source, B2M may also be discussed as beta2-microglobulin and Beta-2-microglobulin.\u003c\/p\u003e\u003cp\u003eReported cellular context includes secreted and cell membrane, which can matter when signal is compared across treatments or changing cell states. Following B2M across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eB2M is commonly interpreted in the context of cancer and immunology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans secreted and cell membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between secreted and cell membrane across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for B2M. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in B2M reflect biology rather than handling. When interpreting B2M, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep B2M trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577570795865,"sku":"F0921-20UL","price":139.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577570828633,"sku":"F0921-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577570861401,"sku":"F0921-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0921-IF.png?v=1773599101","url":"https:\/\/absource.de\/products\/b2m-antibody-sc-f0921","provider":"Absource Diagnostics","version":"1.0","type":"link"}